News. Analysis. Insight.™ - 100 Years of Journalistic Excellence

Johnson & Johnson is engaged in the worldwide manufacture and sale of a range of products in the health care field, and operates via three segments: Consumer; Pharmaceutical and Medical Devices; and Diagnostics. Co.'s Consumer segment includes a range of products used in the baby and child care, skin care, oral and wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products. Co.'s Pharmaceutical segment includes products used as therapeutics. Co.'s Medical Devices and Diagnostics segment includes a range of products used primarily in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics.

Industry	Health
Sector	Pharmaceuticals
# of Employees	122,200
Shares Outstanding	2.8B
Market Cap	179.2B
Enterprise Value	163.8B

52-Week High	$65.28
52-Week Low	$46.25
P/E Ratio	14.18
EPS	$4.58/shr
Dividend	$1.96/shr
Yield	3.02%

Mr. Russell C. Deyo

Chief Compliance Officer; Vice President; General Counsel

Mr. William C. Weldon

Chief Executive Officer; Chairman

Mr. Dominic J. Caruso

Chief Financial Officer; Vice President

S. J. Cosgrove

Controller

Ms. Colleen A. Goggins

Division Officer

Mr. Joseph C. Scodari

Division Officer

Mr. Nicholas J. Valeriani

Division Officer

Ms. Kaye I. Foster-Cheek

Vice President

Ms. Christine A. Poon

Vice-Chairman

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs